Greg C. Garland, chairman and chief executive of Phillips 66, was named on Wednesday as director of Amgen Inc.

The Thousand Oaks biotech said Garland will serve on the Governance and Nominating Committee and the Audit Committee. He will be among 12 independent directors on Amgen’s 13-member board.

“In addition to his leadership experiences as a chief executive officer, Greg brings more than 30 years of international experience in a highly regulated industry," said Robert A. Bradway, chairman and chief executive of Amgen.

Amgen also declared a 47 cent per share dividend for the fourth quarter. It will be paid on Dec. 6 to all stockholders of record on Nov. 14.

Shares of Amgen closed up $2.84, or about 2.5 percent, to $114.28 on the Nasdaq.

In other news, Ryland Group Inc. opened Westmont, a community of single-family homes in suburban Indianapolis.

The Westlake Village home builder’s project in Carmel features houses up to five bedrooms with side entry three-car garages on the largest estates. Prices start at about $360,000.

Last year, Ryland announced plans to build four additional housing communities in the Indianapolis area, with prices in the $130,000 to $160,000 range.

Shares of Ryland closed up 95 cents, or 2.5 percent, to $38.83 on the New York Stock Exchange.